Skip to main content

Country-level interventions for the prevention and management of hypertension through the modification of social determinants of health: a systematic review protocol

Abstract

Background

Hypertension is one of the public health challenges. Various risk factors are associated with hypertension, including social demographics, geographical location, health behaviours, and social stress. Interventions in the social determinants of health can improve hypertension and health promotion. Accordingly, different sectors such as agriculture, housing, education, and transportation should cooperate. This systematic review examines policies as a set of activities and actions/interventions aimed at the modification of the social determinants of health to prevent hypertension.

Methods

A systematic search will be conducted in Medline (via Ovid), PubMed, EMBASE, Cochrane Library, ProQuest Dissertations & Theses, and scientific Persian databases including SID and Magiran. There will be no time restriction. The quality of selected studies will be assessed using an appropriate Joanna Briggs Institute (JBI) Critical Appraisal Checklists according to the type of studies. Two independent researchers will carry out screening and quality assessment. Disagreement between two researchers will be resolved by a third party.

Discussion

Recommendations will be made for policymakers in order to make better evidence-based decisions about the prevention and management of hypertension with regard to the social determinants of health.

Systematic review registration

PROSPERO CRD42020152298

Peer Review reports

Background

The non-communicable diseases are one of the most important health and development challenges in the twenty-first century, both affecting the individuals, and social and economic structure of countries, especially low- and middle-income countries [1]. Among the non-communicable diseases, hypertension is one of the public health challenges. The major factors contributing to the development of hypertension and its complications are social determinants of health such as globalisation, urbanisation, ageing, income, and housing causing behavioural risk factors. On the other hand, behavioural risk factors such as unhealthy diet, smoking, physical inactivity, and harmful alcohol consumption cause obesity and hypertension, which finally lead to cardiovascular diseases (heart attacks, strokes, and heart failure) [2].

The social determinants of health are “conditions in which the individuals are born, grow, live, work, and grow old” [3, 4]. A range of social, ecological, commercial, political, and cultural factors affecting the health are identified as determinants of health [5]. These conditions are often distributed in a disparate way among the individuals and social groups, resulting unequal outcomes of health [6]. These are complex and interactive factors that contribute to the current state of health, the chance of health maintenance and causing diseases. Factors such as housing, environmental state, genetics, income, education, and relationships with friends and family have a remarkable effect on the health [5]. The effect of social determinants on the health is far greater than the performance of the health system. Investing in providing these services in social determinants widely improves the community health indices [7]. Studies show that investing in social determinants of health such as housing and income support will provide positive results [4, 8]. The social determinants of health are established by political systems, resources, and value systems. The multi-level interventions in social determinants of health in the form of policies and plans can improve the outcomes related to the behaviour, risk, damage, well-being, quality of life, and health equity [9].

The College of American Physicians suggests policymakers to adopt a “Health in All Policies” approach and support the integration of health considerations into the community planning decisions via the use of “health impact assessment” [4]. Accordingly, different sectors (such as trade, agriculture, housing, education, transportation, and environment) should cooperate to adopt policies in order to protect the individuals and minimise their exposure to risks. For example, the use of fiscal policies to reduce tobacco use, environmental and labour laws to reduce exposure to smoke is developed and none of these activities is in the main range of health system [10]. On April 7, 2013, the World Health Day, World Health Organisation (WHO) launched a campaign to manage and prevent hypertension, which encouraged policymakers and other stakeholders to prioritise prevention, early diagnosis, and hypertension management in national policies, plans, and activities [11].

Studies show that various risk factors are associated with hypertension, including social demographics (higher age, gender, low education, and family income) [12,13,14,15,16,17], geographical location (urban accommodation) [12, 18], body weight status, health behaviours, and psychological and social stress and support [12]. Some studies show that hypertension is associated with psychological stress such as depression [12, 19], low level of satisfaction with life [12, 20, 21], low social cohesion [12], and lack of social support [12, 22]. The interaction of social conditions, individual lifestyles, and biological factors is critical in health policy [23].

In order to reduce the negative health outcomes associated with social determinants of health, a comprehensive approach is needed including support of public policies, better understanding by physicians, interpersonal communications improvement, organisational and social participation, appropriate financing, health considerations in the community planning and development, and robust planning in research and real evidence collection. The specific objectives of this review are as follows:

1. To identify successful interventions and policies aimed at modifying social determinants of health in the various social contexts and countries around the world that reduce the incidence, prevalence, and severity of hypertension

2. To document the reasons for the success of these policies and interventions

Methods/design

Study method

The systematic review protocol has been developed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) guidelines [24] (see Additional file 1). This protocol has been registered in PROSPERO (registration number CRD42020152298).

Research questions

  1. 1.

    What policies and interventions have been implemented aimed at controlling the social determinants of health in various countries around the world as measures to reduce the incidence of hypertension?

  2. 2.

    What has led to the success of various interventions within one country or in different countries around the world?

Eligibility criteria

We will include studies that focused on the policies applied to intervene in the social determinants of health for the prevention and management of hypertension. The policies are specific decisions, plans, and objectives pursued by governments, organisations, and institutions for the prevention and management of hypertension. This systematic review examines policies as a set of activities and actions/interventions aimed at the modification of the social determinants of health to prevent hypertension.

The criteria for study eligibility in this review including population, context, and outcome are described below.

Population

All countries that have implemented policies/interventions in their population to control or modify social determinants of health as a measure against hypertension.

Intervention

The policies and interventions that have been implemented in different settings including communities, worksites, schools, and health care organisations. These policies/interventions will include economic, social, and nutrioktional policies; educational programmes; and other policies that are effective for the prevention and management of hypertension. This study examines policies and interventions in the ten social determinants of health. These ten social determinants of health will include food, addiction, transportation, social support, stress, social exclusion, early life, work, social gradient, and unemployment.

Context

The study’s context is all countries in the world with the rising prevalence of hypertension.

Outcome

The outcomes are all policies and interventions that have succeeded in reducing the incidence/prevalence of hypertension or average blood pressure of various age groups over time through modifications of social determinants of health, and the documented reasons for each successful policy/intervention.

Types of studies

All original research papers (quantitative, qualitative, and mixed method) aimed to intervene in the social determinants of health for the prevention and management of hypertension will be included. Studies that are focused on other non-communicable diseases will be excluded. Studies with inadequate or incomplete data will be excluded from the study. English and Persian language studies will also be included.

Search strategy

The following databases will be searched: Medline (via Ovid), PubMed, EMBASE, Cochrane Library, and ProQuest Dissertations & Theses. Persian database including SID and Magiran will be searched. For each database, the appropriate search strategy will be implemented. The search strategy will include both free text and controlled vocabularies. We will hand-search reference lists of included studies and reference lists of relevant systematic reviews. We will supplement the electronic database searches with website and grey literature searches. We will search websites of relevant institutions and organisations such as the World Health Organisation. Other websites might be reviewed when undertaking the research. No date of publication restriction will be applied. An initial search strategy of Medline (Ovid) is given as additional file 2.

Study selection

All retrieved papers will be imported in the Endnote software. After eliminating the duplicated papers, the titles and abstracts of the papers will be screened according to the inclusion and exclusion criteria and eligible studies will be selected. The selected papers will be reviewed in full text, and the final decision will be made regarding the study inclusion and exclusion criteria. The retrieved papers will be screened by two researchers (F-A-B and M-GH). Any disagreement between the two researchers will be resolved by a third party (A-J). The studies that met the inclusion criteria will be assessed for their quality, and the data of included studies will be extracted in accordance with the data extraction form. The studies that are not eligible for inclusion in the study will be reported separately in the table with reasons.

Quality assessment

The quality of the included studies will be assessed by an appropriate Joanna Briggs Institute (JBI) Critical Appraisal Checklists according to the type of studies [25]. The JBI has separate checklists for cohort studies (11 criteria), cross-sectional studies (8 criteria), case-control studies (10 criteria), RCT studies (13 criteria), quasi-experimental studies (9 criteria), and qualitative studies (10 criteria). Options for checklist responses included “yes”, “no”, “unclear”, or “not applicable”. For example, the following items will be used to appraise cohort and cross-sectional studies: appropriateness of inclusion criteria, description of participants and setting, valid and reliable measurement of exposure, objective and standard criteria used, identification of confounder, strategies to handle confounder, outcome measurement, and appropriate statistical analysis. The risk of bias for study will be independently assessed by two reviewers (F-A-B and R-KH-Z). Any disagreement between the two authors will be resolved by the third party (A-J). According to the quality, studies will be reported in separate tables. The quality of studies will be graded high, medium, low:

High—a rigorous and robust scientific approach

Medium—some flaws and medium scientific value

Low—serious flaws and poor scientific value

Data extraction

A data extraction form will be designed for data collection. The extracted data will be collected by using Excel 2016.The extracted data from studies will include items such as the authors’ name, publication year, country, context, study design, study methodology, target group, number of participants, policies, and actions taken and implemented. These items will be selected according to the key questions of the study. The data extraction will be done by all of the authors (F-A-B, M-GH, A-J, MZ-P, MZ-P, and F-S-GH). The draft of data extraction form will be modified during the data extraction process by the team.

Data synthesis

Using information taken by the data extraction table, we will conduct a thematic analysis. Thematic analysis is appropriate for this review for two reasons. It fits our current objective of aggregating existing evidence, and also, thematic analysis has good transparency in delivering accessible results. The thematic analysis involves three steps of analysis. First, the data are classified. Then, the similarities between the data are identified. The third stage of thematic analysis includes the development of analytical themes. The data extracted (including all successful actions, initiatives, programmes in social determinants of health and successful reasons for each outcome) are classified. Then, the similarities between those are identified. In the final will be determined themes.

Discussion

Hypertension is the most important preventable cause of cardiovascular disease in the world [26]. In Iran, as a developing country, cardiovascular disease is the leading cause of death [27, 28]. It is necessary to use the social determinants of health approach, to identify policies that prevent incidence of hypertension. We expect that the results of this systematic review produce valuable evidence for policymakers in health policy. These policies will be useful for policymakers, officials and planners, which are in cooperation and consultation with citizens and organisations and government, to suggest policies for the prevention of hypertension and reduce the burden of disease imposed on society.

Strengths and limitations of this study

The strengths of this review include a systematic approach to search for articles. The quality of studies is assessed using appropriate and valid tools. This review provides a credible documentary for policymakers to make evidence-based decisions. The limitation of this review is that it includes studies published in both English and Persian, and some countries publish articles in their official language, so valuable policies may not be included in this review and may be lost.

Availability of data and materials

Not applicable

Abbreviations

JBI:

Joanna Briggs Institute

PRISMA:

Preferred Reporting Items for Systematic Review and Meta-Analysis Statement

PROSPERO:

International Prospective Register of Systematic Reviews

SID:

Scientific Information Database

References

  1. 1.

    Global status report on noncommunicable diseases 2014 [Available from: https://apps.who.int/iris/bitstream/handle/10665/148114/9789241564854_eng.pdf?...

  2. 2.

    WHO. A global brief on hypertension silent killer, global public health crisis 2013 [Available from:https://apps.who.int/iris/bitstream/handle/10665/79059/WHO_DCO_WHD_2013.2_eng.pdf;jsessionid = 05C84E752E42E011791AFE5800A54105?sequence = 1.

  3. 3.

    Council O. Policy on social determinants of children’s oral health and health disparities. Oral health; 2017.

  4. 4.

    Daniel H, Bornstein SS, Kane GC. Addressing social determinants to improve patient care and promote health equity: an American College of Physicians position paper. Ann Intern Med. 2018;168(8):577–8.

    Article  Google Scholar 

  5. 5.

    Asturalia pha. What are the determinants of health? public health association Asturalia [cited 2019. Available from: https://www.phaa.net.au/documents/item/2756.

  6. 6.

    Saunders M, Barr B, McHale P, Hamelmann C. Key policies for addressing the social determinants of health and health inequities; 2017.

    Google Scholar 

  7. 7.

    Bahadori M, Sanaeinasab H, Ghanei M, Tavana AM, Ravangard R, Karamali M. The social determinants of health (SDH) in Iran: a systematic review article. Iran J Public Health. 2015;44(6):728.

    PubMed  PubMed Central  Google Scholar 

  8. 8.

    Taylor LA, Tan AX, Coyle CE, Ndumele C, Rogan E, Canavan M, et al. Leveraging the social determinants of health: what works? PLoS One. 2016;11(8):e0160217.

    Article  Google Scholar 

  9. 9.

    Deatrick JA. Where is “family” in the social determinants of health? Implications for family nursing practice, research, education, and policy. Los Angeles, CA: SAGE Publications CA; 2017.

    Google Scholar 

  10. 10.

    Rasanathan K, Krech R. Action on social determinants of health is essential to tackle noncommunicable diseases. Bull World Health Organ. 2011;89:775–6.

    Article  Google Scholar 

  11. 11.

    WHO. World Health Day 2013 2013 [Available from: http://www.emro.who.int/world-health-days/2013/overview.html.

  12. 12.

    Peltzer K, Pengpid S. The prevalence and social determinants of hypertension among adults in Indonesia: a cross-sectional population-based national survey. Int J Hypertens. 2018.

  13. 13.

    Hussain MA, Al Mamun A, Reid C, Huxley RR. Prevalence, awareness, treatment and control of hypertension in Indonesian adults aged≥ 40 years: findings from the Indonesia family life survey (IFLS). PLoS One. 2016;11(8):e0160922.

    Article  Google Scholar 

  14. 14.

    Katulanda P, Ranasinghe P, Jayawardena R, Constantine GR, Rezvi Sheriff M, Matthews DR. The prevalence, predictors and associations of hypertension in Sri Lanka: a cross-sectional population based national survey. Clin Exp Hypertens. 2014;36(7):484–91.

    Article  Google Scholar 

  15. 15.

    Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–68.

    CAS  Article  Google Scholar 

  16. 16.

    Cuschieri S, Vassallo J, Calleja N, Pace N, Mamo J. The effects of socioeconomic determinants on hypertension in a cardiometabolic at-risk European country. Int J Hypertens. 2017.

  17. 17.

    Hendriks ME, Wit FW, Roos MT, Brewster LM, Akande TM, De Beer IH, et al. Hypertension in sub-Saharan Africa: cross-sectional surveys in four rural and urban communities. PLoS One. 2012;7(3):e32638.

    CAS  Article  Google Scholar 

  18. 18.

    Bjertness MB, Htet AS, Meyer HE, Htike MMT, Zaw KK, Oo WM, et al. Prevalence and determinants of hypertension in Myanmar-a nation wide cross-sectional study. BMC Public Health. 2016;16(1):590.

    Article  Google Scholar 

  19. 19.

    Ginty A, Carroll D, Roseboom T, Phillips A, De Rooij S. Depression and anxiety are associated with a diagnosis of hypertension 5 years later in a cohort of late middle-aged men and women. J Hum Hypertens. 2013;27(3):187.

    CAS  Article  Google Scholar 

  20. 20.

    Martinez VR, Silva E, Villasmil J. Relationship between life satisfaction levels and high blood pressure in adolescents: PP. 14.43. J Hypertens. 2010;28:e260.

    Article  Google Scholar 

  21. 21.

    Mojon-Azzi S, Sousa-Poza A. Hypertension and life satisfaction: an analysis using data from the survey of health, ageing and retirement in Europe. Appl Econ Lett. 2011;18(2):183–7.

    Article  Google Scholar 

  22. 22.

    Cuffee Y, Ogedegbe C, Williams NJ, Ogedegbe G, Schoenthaler A. Psychosocial risk factors for hypertension: an update of the literature. Curr Hypertens Rep. 2014;16(10):483.

    Article  Google Scholar 

  23. 23.

    Tan ST, Quek RYC, Haldane V, Koh JJK, Han EKL, Ong SE, et al. The social determinants of chronic disease management: perspectives of elderly patients with hypertension from low socio-economic background in Singapore. Int J Equity Health. 2019;18(1):1.

    Article  Google Scholar 

  24. 24.

    Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.

    Article  Google Scholar 

  25. 25.

    Institute JBI. Critical appraisal tools. [Available from: https://joannabriggs.org/ebp/critical_appraisal_tools.

  26. 26.

    Mohsenzadeh Y, Motedayen M, Hemmati F, Sayehmiri K, Sarokhani MT, Sarokhani D. Investigating the prevalence rate of hypertension in Iranian men and women: a study of systematic review and meta-analysis. JBRMS. 2017;4(1):53–62.

    Article  Google Scholar 

  27. 27.

    Sadeghi M, Haghdoost AA, Bahrampour A, Dehghani M. Modeling the burden of cardiovascular diseases in Iran from 2005 to 2025: the impact of demographic changes. Iran J Public Health. 2017;46(4):506.

    PubMed  PubMed Central  Google Scholar 

  28. 28.

    Forouzanfar MH, Sepanlou SG, Shahraz S, Nanghavi P, Pourmalek F, Lozano R, et al. Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010. Arch Iran Med. 2014;17(5):304.

    PubMed  Google Scholar 

Download references

Acknowledgements

We would like to appreciate Sara Arabi Basharic, Saba Arabi Basharic, Morteza Arab-Zozani, Habib Jalilian, and Edris Kakemam for their valuable advice.

Funding

This protocol systematic review is a part of a Ph.D. project. Funding is provided by the School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran. The funder had no involvement in the study design, the writing of the manuscript, or the submission for publication.

Author information

Affiliations

Authors

Contributions

M-GH conceptualised the research idea. F-A-B initiated the protocol and wrote the manuscript. A-J and MZ-P contributed to the design of protocol and provided the critical revision of the manuscript. R-KH-Z drafted the inclusion and exclusion criteria and provided the data extraction form. F-S-GH helped to formulate the search strategy, reviewed the whole manuscript, and provided substantial comments for editing. All authors critically reviewed the study protocol and approved the final manuscript

Corresponding author

Correspondence to Masoumeh Gholizadeh.

Ethics declarations

Ethics approval and consent to participate

Not applicable

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This systematic review protocol will form part of F-A-B’s PhD dissertation.

Supplementary information

Additional file 1:.

PRISMA-P-checklist

Additional file 2:.

Search strategy

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Arabi Basharic, F., Janati, A., Pezeshki, M.Z. et al. Country-level interventions for the prevention and management of hypertension through the modification of social determinants of health: a systematic review protocol. Syst Rev 9, 152 (2020). https://doi.org/10.1186/s13643-020-01392-9

Download citation

Keywords

  • Social determinants of health
  • Policy
  • Hypertension